These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 18359398)

  • 1. Metabolic syndrome and uric acid nephrolithiasis.
    Sakhaee K; Maalouf NM
    Semin Nephrol; 2008 Mar; 28(2):174-80. PubMed ID: 18359398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis.
    Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and the genesis of uric acid stones.
    Maalouf NM
    J Ren Nutr; 2011 Jan; 21(1):128-31. PubMed ID: 21195936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis as a systemic disorder.
    Sakhaee K
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):304-9. PubMed ID: 18408483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.
    Abate N; Chandalia M; Cabo-Chan AV; Moe OW; Sakhaee K
    Kidney Int; 2004 Feb; 65(2):386-92. PubMed ID: 14717908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes increases the risk for uric acid stones.
    Daudon M; Traxer O; Conort P; Lacour B; Jungers P
    J Am Soc Nephrol; 2006 Jul; 17(7):2026-33. PubMed ID: 16775030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid nephrolithiasis.
    Halabe A; Sperling O
    Miner Electrolyte Metab; 1994; 20(6):424-31. PubMed ID: 7783706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone.
    Maalouf NM; Poindexter JR; Adams-Huet B; Moe OW; Sakhaee K
    Kidney Int; 2019 May; 95(5):1262-1268. PubMed ID: 30795852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beware the low urine pH--the major cause of the increased prevalence of nephrolithiasis in the patient with type 2 diabetes.
    Bell DS
    Diabetes Obes Metab; 2012 Apr; 14(4):299-303. PubMed ID: 21992452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uric acid nephrolithiasis.
    Cameron MA; Sakhaee K
    Urol Clin North Am; 2007 Aug; 34(3):335-46. PubMed ID: 17678984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary pH and stone formation.
    Wagner CA; Mohebbi N
    J Nephrol; 2010; 23 Suppl 16():S165-9. PubMed ID: 21170875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uric acid nephrolithiasis].
    Dussol B
    Rev Prat; 2011 Mar; 61(3):389-92. PubMed ID: 21563421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic syndrome and nephrolithiasis].
    Kohjimoto Y; Iba A; Sasaki Y; Hara I
    Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of nephrolithiasis with hypertension and obesity: a review.
    Obligado SH; Goldfarb DS
    Am J Hypertens; 2008 Mar; 21(3):257-64. PubMed ID: 18219300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and clinical pathophysiology of uric acid kidney stones.
    Sakhaee K
    J Nephrol; 2014 Jun; 27(3):241-5. PubMed ID: 24497296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid stone disease: lessons from recent human physiologic studies.
    Tran TVM; Maalouf NM
    Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):407-413. PubMed ID: 32398609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.